Position in LNTH
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$15,391,039
+$1,968,093 QoQ
Shares Held
138,733
-21.6% QoQ
Ownership
0.213%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#71
of 466 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in LNTH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026THOMPSON SIEGEL & WALMSLEY LLC holds $144,286,637 across 7 Drug Manufacturers - Specialty & Generic names. LNTH ranks #4 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
766,798 | $55,102,104 | |
| 2 | PRGO |
PERRIGO Co plc
|
3,318,826 | $34,482,602 | |
| 3 | VTRS |
Viatris Inc
|
1,282,665 | $20,368,720 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
This page
|
138,733 | $15,391,039 | |
| 5 | ETON |
Eton Pharmaceuticals, Inc.
|
297,232 | $10,759,798 | |
| 6 | ANIP |
Ani Pharmaceuticals Inc
|
92,691 | $7,672,960 | |
| 7 | XERS |
Xeris Biopharma Holdings, Inc.
|
64,320 | $509,414 |
All Filings in LNTH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,391,039 | 138,733 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $13,422,946 | 176,967 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $15,608,038 | 234,531 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $14,063,410 | 274,194 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $12,033,256 | 146,998 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $13,373,347 | 137,022 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $14,131,459 | 157,964 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $8,372,169 | 76,284 | Shares | Defined | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||